8-K
filed April 3, 2024, 7:59 PM ET
ticker SLB
CIK 0000087347
other material
confidence high
sentiment neutral
materiality 0.15
SLB shareholders elect all 11 directors and approve all proposals at 2024 annual meeting
SLB LIMITED/NV
- All 11 director nominees elected; each received over 86% of votes cast.
- Advisory vote on executive compensation approved with ~97.3% of votes cast.
- Financial statements and 2023 dividends approved with ~99.9% of votes cast.
- Ratification of PricewaterhouseCoopers as independent auditors for 2024 approved with ~93.0% of votes cast.
- Meeting held April 3, 2024; all proposals passed as described in the definitive proxy statement.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SLB LIMITED/NV shareholders approved Item 4—Independent Registered Public Accounting Firm at the 2024-04-03 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-04-03
Exact text from the filing
Item 4—Independent Registered Public Accounting Firm The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the independent auditors of SLB for 2024, as described in the Definitive Proxy Statement, was approved with approximately 93.0% of the votes cast at the Annual Meeting voting for the proposal. For Against Abstain Broker Non-votes 1,118,542,634 83,939,218 1,367,053 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SLB LIMITED/NV shareholders approved Item 1—Election of Directors at the 2024-04-03 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-04-03
Exact text from the filing
Item 1—Election of Directors All director nominees were elected at the Annual Meeting. For Against Abstain Broker Non-votes Peter Coleman 1,014,817,161 62,138,559 709,305 126,183,880 Patrick de La Chevardière 1,062,570,978 14,357,327 736,720 126,183,880 Miguel Galuccio 1,012,577,734 64,304,411 782,880 126,183,880 Jim Hackett 1,007,387,133 69,048,667 1,229,225 126,183,880 Olivier Le Peuch 1,074,052,731 3,001,536 610,758 126,183,880 Samuel Leupold 1,073,991,735 2,896,566 776,724 126,183,880 Tatiana Mitrova 1,073,347,200 3,124,551 1,193,274 126,183,880 Maria Moræus Hanssen 1,033,092,370 43,846,145 726,510 126,183,880 Vanitha Narayanan 947,786,313 128,393,804 1,484,908 126,183,880 Jeff Sheets 1,061,561,712 15,234,354 868,959 126,183,880 Ulrich Spiesshofer 1,073,718,739 3,210,409 735,877 126,183,880
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SLB LIMITED/NV shareholders approved Item 3—Financial Statements and Dividends at the 2024-04-03 meeting.
- Outcome
- passed
- Meeting
- 2024-04-03
Exact text from the filing
Item 3—Financial Statements and Dividends The proposal to approve SLB’s consolidated balance sheet at December 31, 2023, its consolidated statement of income for the year ended December 31, 2023, and the declarations of dividends by SLB’s Board of Directors in 2023 as reflected in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as described in the Definitive Proxy Statement, was approved with approximately 99.9% of the votes cast at the Annual Meeting voting for the proposal. For Against Abstain Broker Non-votes 1,073,792,269 433,161 3,439,595 126,183,880
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SLB LIMITED/NV shareholders approved Item 2—Advisory Approval of Executive Compensation at the 2024-04-03 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-04-03
Exact text from the filing
Item 2—Advisory Approval of Executive Compensation The advisory resolution to approve SLB’s executive compensation, as described in the Definitive Proxy Statement, was approved with approximately 97.3% of the votes cast at the Annual Meeting voting for the proposal. For Against Abstain Broker Non-votes 1,042,753,005 28,606,338 6,305,682 126,183,880
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.